Cargando…

Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy

BACKGROUND: Both plastic stents and self-expandable metallic stents (SEMSes) are used for endoscopic biliary decompression (BD) among patients with pancreatic cancer (PAC). Cholangitis or stent occlusion often interrupts or ends chemotherapy. We investigated cholangitis, stent occlusion, and chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Vehviläinen, Sini, Seppänen, Hanna, Nurmi, Anna, Haglund, Caj, Mustonen, Harri, Udd, Marianne, Kylänpää, Leena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741707/
https://www.ncbi.nlm.nih.gov/pubmed/33534073
http://dx.doi.org/10.1007/s00464-021-08327-y
_version_ 1784629550793097216
author Vehviläinen, Sini
Seppänen, Hanna
Nurmi, Anna
Haglund, Caj
Mustonen, Harri
Udd, Marianne
Kylänpää, Leena
author_facet Vehviläinen, Sini
Seppänen, Hanna
Nurmi, Anna
Haglund, Caj
Mustonen, Harri
Udd, Marianne
Kylänpää, Leena
author_sort Vehviläinen, Sini
collection PubMed
description BACKGROUND: Both plastic stents and self-expandable metallic stents (SEMSes) are used for endoscopic biliary decompression (BD) among patients with pancreatic cancer (PAC). Cholangitis or stent occlusion often interrupts or ends chemotherapy. We investigated cholangitis, stent occlusion, and chemotherapy interruption rates for SEMSes and plastic stents among patients receiving chemotherapy for PAC. MATERIALS AND METHODS: We retrospectively analyzed data for 293 PAC patients who received a biliary stent at Helsinki University Hospital during 2000–2017. Patients received chemotherapy as palliative treatment (PT: n = 187) or neoadjuvant treatment (NAT: n = 106). Among participants, 229 had a plastic stent (PT: n = 138, NAT: n = 91) and 64 had a SEMS (PT: n = 49, NAT: n = 15). RESULTS: Overall, 15.6% (n = 10) of patients with SEMSes (PT: 20.4%, n = 10, NAT: 0%) and 53.0% (n = 121) of patients with plastic stents (PT: 69.3%, n = 95, NAT: 28.5%, n = 26) experienced one or more stent complications (p < 0.001). Cholangitis developed in 6.3% (n = 8) of PT patients with SEMSes. No patients with SEMSes receiving NAT (n = 15) experienced cholangitis. However, 31.9% (PT: 42.8%, n = 59, p = 0.001; NAT: 15.4%, n = 14, p = 0.211) of patients with plastic stents developed cholangitis. Among all patients receiving NAT or PT, cholangitis interrupted chemotherapy 6 times (9.4%) in SEMS patients and 61 times (26.6%) in plastic stent patients (p = 0.004). Stent occlusion without cholangitis interrupted NAT or PT 2 times (2.1%) in SEMS patients and 31 times (13.5%) in plastic stent patients (p = 0.023). CONCLUSIONS: SEMS is recommended for BD among patients with PAC receiving chemotherapy. Among both PT and NAT patients, patients with SEMS experience a lower stent failure rate, lower rate of cholangitis, and fewer chemotherapy interruptions than patients with plastic stents. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00464-021-08327-y.
format Online
Article
Text
id pubmed-8741707
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-87417072022-01-20 Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy Vehviläinen, Sini Seppänen, Hanna Nurmi, Anna Haglund, Caj Mustonen, Harri Udd, Marianne Kylänpää, Leena Surg Endosc Article BACKGROUND: Both plastic stents and self-expandable metallic stents (SEMSes) are used for endoscopic biliary decompression (BD) among patients with pancreatic cancer (PAC). Cholangitis or stent occlusion often interrupts or ends chemotherapy. We investigated cholangitis, stent occlusion, and chemotherapy interruption rates for SEMSes and plastic stents among patients receiving chemotherapy for PAC. MATERIALS AND METHODS: We retrospectively analyzed data for 293 PAC patients who received a biliary stent at Helsinki University Hospital during 2000–2017. Patients received chemotherapy as palliative treatment (PT: n = 187) or neoadjuvant treatment (NAT: n = 106). Among participants, 229 had a plastic stent (PT: n = 138, NAT: n = 91) and 64 had a SEMS (PT: n = 49, NAT: n = 15). RESULTS: Overall, 15.6% (n = 10) of patients with SEMSes (PT: 20.4%, n = 10, NAT: 0%) and 53.0% (n = 121) of patients with plastic stents (PT: 69.3%, n = 95, NAT: 28.5%, n = 26) experienced one or more stent complications (p < 0.001). Cholangitis developed in 6.3% (n = 8) of PT patients with SEMSes. No patients with SEMSes receiving NAT (n = 15) experienced cholangitis. However, 31.9% (PT: 42.8%, n = 59, p = 0.001; NAT: 15.4%, n = 14, p = 0.211) of patients with plastic stents developed cholangitis. Among all patients receiving NAT or PT, cholangitis interrupted chemotherapy 6 times (9.4%) in SEMS patients and 61 times (26.6%) in plastic stent patients (p = 0.004). Stent occlusion without cholangitis interrupted NAT or PT 2 times (2.1%) in SEMS patients and 31 times (13.5%) in plastic stent patients (p = 0.023). CONCLUSIONS: SEMS is recommended for BD among patients with PAC receiving chemotherapy. Among both PT and NAT patients, patients with SEMS experience a lower stent failure rate, lower rate of cholangitis, and fewer chemotherapy interruptions than patients with plastic stents. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00464-021-08327-y. Springer US 2021-02-03 2022 /pmc/articles/PMC8741707/ /pubmed/33534073 http://dx.doi.org/10.1007/s00464-021-08327-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Vehviläinen, Sini
Seppänen, Hanna
Nurmi, Anna
Haglund, Caj
Mustonen, Harri
Udd, Marianne
Kylänpää, Leena
Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy
title Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy
title_full Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy
title_fullStr Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy
title_full_unstemmed Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy
title_short Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy
title_sort use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741707/
https://www.ncbi.nlm.nih.gov/pubmed/33534073
http://dx.doi.org/10.1007/s00464-021-08327-y
work_keys_str_mv AT vehvilainensini useofselfexpandablemetallicstentsforendoscopicbiliarydecompressiondecreasesstentcomplicationsinpancreaticcancerpatientsreceivingchemotherapy
AT seppanenhanna useofselfexpandablemetallicstentsforendoscopicbiliarydecompressiondecreasesstentcomplicationsinpancreaticcancerpatientsreceivingchemotherapy
AT nurmianna useofselfexpandablemetallicstentsforendoscopicbiliarydecompressiondecreasesstentcomplicationsinpancreaticcancerpatientsreceivingchemotherapy
AT haglundcaj useofselfexpandablemetallicstentsforendoscopicbiliarydecompressiondecreasesstentcomplicationsinpancreaticcancerpatientsreceivingchemotherapy
AT mustonenharri useofselfexpandablemetallicstentsforendoscopicbiliarydecompressiondecreasesstentcomplicationsinpancreaticcancerpatientsreceivingchemotherapy
AT uddmarianne useofselfexpandablemetallicstentsforendoscopicbiliarydecompressiondecreasesstentcomplicationsinpancreaticcancerpatientsreceivingchemotherapy
AT kylanpaaleena useofselfexpandablemetallicstentsforendoscopicbiliarydecompressiondecreasesstentcomplicationsinpancreaticcancerpatientsreceivingchemotherapy